Skip to main content

Regulatory compliance

The TGA monitors and enforces regulatory compliance in relation to therapeutic goods. This supports consumer protection and a fair market for industry.

Latest alerts

  • EVE Allylisopropylacetylurea tablets

    The TGA is warning consumers against taking EVE branded products that contain allylisopropylacetylurea (apronal) as they pose a significant health risk and are prohibited from sale, supply or use in Australia.
  • Counterfeit semaglutide vials

    The TGA has detected fake semaglutide, also known as Ozempic, being illegally imported into Australia.

Latest articles

Latest publications

Help us improve the Therapeutic Goods Administration site